Matches in Wikidata for { <http://www.wikidata.org/entity/Q83891048> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q83891048 description "artículu científicu espublizáu n'abril de 2012" @default.
- Q83891048 description "im April 2012 veröffentlichter wissenschaftlicher Artikel" @default.
- Q83891048 description "scientific article published on 06 April 2012" @default.
- Q83891048 description "wetenschappelijk artikel" @default.
- Q83891048 description "наукова стаття, опублікована у квітні 2012" @default.
- Q83891048 name "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 name "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 type Item @default.
- Q83891048 label "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 label "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 prefLabel "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 prefLabel "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 P1433 Q83891048-457A6E01-6BBD-4BA4-98C1-D5C6E9BCC479 @default.
- Q83891048 P1476 Q83891048-95FA5A9F-026A-41D7-B674-33DC054BD096 @default.
- Q83891048 P2093 Q83891048-6C27F446-DB39-4421-80C1-91482C304874 @default.
- Q83891048 P2093 Q83891048-92B9D57E-E1E2-4C47-A4E8-8E82C0B137F1 @default.
- Q83891048 P2093 Q83891048-9A096197-E65B-4C8D-A38A-4E026461DE82 @default.
- Q83891048 P2093 Q83891048-BFA4F3EA-A2BA-4966-AE92-C9EAADEE00B6 @default.
- Q83891048 P2093 Q83891048-C55EA794-9416-4E2A-8631-4DAC3700E82E @default.
- Q83891048 P304 Q83891048-CE6AE5F4-6FFC-4F60-8B01-506C12F4B886 @default.
- Q83891048 P31 Q83891048-E6C712C5-2BF9-406B-BA54-9BF6738D10CF @default.
- Q83891048 P356 Q83891048-C538ABF7-5254-4180-BA20-DC50F04C6807 @default.
- Q83891048 P433 Q83891048-D5BC1976-52DE-492F-B328-F9E25D5321C2 @default.
- Q83891048 P478 Q83891048-AEB5FD61-F127-496E-A5D9-26C86CA28D10 @default.
- Q83891048 P577 Q83891048-95B65F91-C9DB-4F8A-8BB5-4F1DBA5A928E @default.
- Q83891048 P698 Q83891048-25366817-30DD-4DD8-A924-72E25B02D1DC @default.
- Q83891048 P356 J.PROSTAGLANDINS.2012.03.004 @default.
- Q83891048 P698 22503964 @default.
- Q83891048 P1433 Q15754476 @default.
- Q83891048 P1476 "Complement C5a exhibits anxiolytic-like activity via the prostaglandin D2-DP1 receptor system coupled to adenosine A2A and GABAA receptors" @default.
- Q83891048 P2093 "Chihiro Miyamoto" @default.
- Q83891048 P2093 "Kousaku Ohinata" @default.
- Q83891048 P2093 "Mariko Yoshida" @default.
- Q83891048 P2093 "Masaaki Yoshikawa" @default.
- Q83891048 P2093 "Takafumi Mizushige" @default.
- Q83891048 P304 "17-22" @default.
- Q83891048 P31 Q13442814 @default.
- Q83891048 P356 "10.1016/J.PROSTAGLANDINS.2012.03.004" @default.
- Q83891048 P433 "1-2" @default.
- Q83891048 P478 "98" @default.
- Q83891048 P577 "2012-04-06T00:00:00Z" @default.
- Q83891048 P698 "22503964" @default.